What anastrozole dose do labels, trials and logs show for men on TRT?

Tablet strength and logged doses
BasisStrength or doseSchedule or share
US label11 mg tabletOnce a day, for postmenopausal women with breast cancer
UK summary21 mg tabletOnce a day, for adults including the elderly; uses listed are in postmenopausal women
Logged in Milligram100.5 mg47% of people
Logged in Milligram101 mg26% of people
Logged in Milligram100.25 mg21% of people

The US and UK labels give one 1 mg tablet once a day, and every indication they list is in postmenopausal women with none listed in men or in men on TRT, while in Herzog (2010), a 3-month trial of 40 men who all had biweekly 300 mg depotestosterone cypionate, the anastrozole arm was given 1 mg daily and 0.5 mg is the dose most often logged in Milligram, by 47% of people logging anastrozole.123410

Tablet strength and logged doses

The table is set at the top of the page

The US label supplies 1 mg tablets in bottles of 30, and the UK summary and Canadian monograph also describe a 1 mg tablet.125 The US label describes Arimidex as a tablet for oral use and lists 1 mg tablets as its one strength.1 The 0.5 mg (47% of people) and 0.25 mg (21% of people) that people logged are fractions of the 1 mg in one label tablet, and the US label describes no 0.5 mg or 0.25 mg tablet.101

What the labels say about dose and length

The UK summary gives the same dose for adults including the elderly, and lists its uses as breast cancer in postmenopausal women, including primary prevention in those at moderate or high risk.2 Neither the US label nor the UK summary lists a use in men or in men on TRT.12 For postmenopausal women with hormone receptor-positive early invasive breast cancer, the UK summary gives the recommended duration of adjuvant endocrine treatment as 5 years, and the Canadian monograph says that in the adjuvant setting treatment is currently recommended for 5 years.25 The US label says the optimal duration of adjuvant therapy is unknown, and that in the ATAC trial it was given for five years; the ATAC report by Howell and colleagues (2005) describes anastrozole compared with tamoxifen for 5 years in 9366 postmenopausal women with localised breast cancer.16 For advanced breast cancer, the US label says the tablet is continued until tumor progression.1

Trials in men

TrialDose and schedulePeopleLength
Leder, 2004 (37 men)71 mg daily (12 men), 1 mg twice weekly (11 men), or placebo daily (14 men), by mouth37 elderly men aged 62 to 74 with screening testosterone under 350 ng/dl, given anastrozole to raise their own testosterone12 weeks
Burnett-Bowie, 2009 (88 men)81 mg daily or placebo88 men aged 60 and older with low testosterone and symptoms of hypogonadism1 year
Helo, 2015 (26 men)91 mg a day, or clomiphene 25 mg a day26 hypogonadal infertile men with testosterone under 350 ng/dL and normal LH12 weeks
Herzog, 2010 (40 men)341 mg tablet daily with biweekly intramuscular injections of 300 mg testosterone cypionate, or a placebo tablet with the same injections40 men with focal epilepsy, hyposexuality and hypogonadism3 months

Herzog (2010) is the trial here in which both arms were also given testosterone, as biweekly intramuscular injections of 300 mg depotestosterone cypionate, while Leder (2004) gave anastrozole to 37 elderly men to raise their own testosterone.734

In Leder (2004), total testosterone rose from 343 to 572 ng/dl on 1 mg daily and from 397 to 520 ng/dl on 1 mg twice weekly, both significant against placebo and with a significant difference between the two arms, while estradiol fell from 26 to 17 pg/ml and from 27 to 17 pg/ml, with no difference between them; the authors say the physiological consequences of these changes remain to be determined.7 In Helo (2015), the mean rise in testosterone was 408 ng/dL on 1 mg a day of anastrozole and 571 ng/dL on 25 mg a day of clomiphene, a significantly larger rise with clomiphene, and estradiol fell with anastrozole while it rose with clomiphene.9 In Herzog (2010), normalisation of sexual function was 72.2% with testosterone plus anastrozole and 47.4% with testosterone plus placebo, a difference that was not statistically significant, and estradiol was significantly lower with anastrozole.3 None of the trials cited here tested a dose below 1 mg; each anastrozole arm used 1 mg, daily or twice weekly.7894

Storage

The US label says to store the tablets at controlled room temperature, 20 to 25°C.1 The UK summary says not to store above 30°C.2 The Canadian monograph says to store at room temperature, 15 to 30°C.5

Frequently asked questions

What route is anastrozole taken by?

The UK summary gives the route as oral.2 Of the people who logged anastrozole, 100% logged oral.10

Can the tablet be taken with food?

The US label says the tablet can be taken with or without food.1

How the logged figures are counted

Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.

References

  1. ANI Pharmaceuticals (DailyMed, US National Library of Medicine). ARIMIDEX (anastrozole) tablet, US prescribing information. 2026. dailymed.nlm.nih.gov
  2. AstraZeneca UK Limited (electronic medicines compendium). Arimidex 1 mg film-coated tablets, summary of product characteristics. 2026. medicines.org.uk
  3. Epilepsy Behav, via PubMed. Anastrozole and testosterone versus placebo and testosterone for sexual dysfunction in men with epilepsy and hypogonadism. 2010. pubmed.ncbi.nlm.nih.gov
  4. ClinicalTrials.gov, US National Library of Medicine. Treatment of sexual dysfunction in hypogonadal men with epilepsy with testosterone and either anastrozole or placebo (NCT00179517). 2005. clinicaltrials.gov
  5. AstraZeneca Canada (Health Canada drug product database). ARIMIDEX (anastrozole) product monograph, revised 23 Dec 2024. 2024. pdf.hres.ca
  6. Lancet, via PubMed. Results of the ATAC trial after completion of 5 years' adjuvant treatment for breast cancer. 2005. pubmed.ncbi.nlm.nih.gov
  7. J Clin Endocrinol Metab, via PubMed. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. 2004. pubmed.ncbi.nlm.nih.gov
  8. Clin Endocrinol, via PubMed. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial. 2009. pubmed.ncbi.nlm.nih.gov
  9. J Sex Med, via PubMed. Randomized double-blind comparison of clomiphene citrate and anastrozole in raising testosterone in hypogonadal infertile men. 2015. pubmed.ncbi.nlm.nih.gov
  10. Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted